Skip to main content

Want a detailed portfolio tracker?

ETON
NASDAQ
$41.07

Eton Pharmaceuticals Inc (ETON)

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
Website: https://www.etonpharma.com
68 analysts
Buy
Target: $49.25 (+19.92%)

Market Cap

$1.05B

Revenue 5Y CAGR

+49.00%

Free Cash Flow Yield

1.46%

Beta (5Y)

0.86

Price Chart

Valuation
Market Cap$1.05B
Forward P/E62.50
P/S12.13
P/B33.56
Profitability
Total Revenue (TTM)$87M
Gross Profit (TTM)$52M
EBITDA$6.20M
Profit Margin6.4%
Operating Margin10%
EPS-$0.06
Financial Health
Debt-to-Equity100.4%
Free Cash Flow Yield1.46%
Growth & Risk
EPS 5Y CAGR-38.49%
Revenue 5Y CAGR+49.00%
Beta (5Y)0.86
Sharpe Ratio2.16